106 related articles for article (PubMed ID: 9885629)
1. [Trisomy 18 anomalies on sonography and calculated risk of chromosomal abnormalities during first trimester].
Maymon R; Herman A; Dreazen E; Glasner M; Weinraub Z
Harefuah; 1998 Sep; 135(5-6):180-2, 256, 255. PubMed ID: 9885629
[TBL] [Abstract][Full Text] [Related]
2. Trisomy 18: first-trimester nuchal translucency with pathological correlation.
Jackson S; Porter H; Vyas S
Ultrasound Obstet Gynecol; 1995 Jan; 5(1):55-6. PubMed ID: 7850592
[TBL] [Abstract][Full Text] [Related]
3. Chromosomal defects and outcome in 1015 fetuses with increased nuchal translucency.
Pandya PP; Kondylios A; Hilbert L; Snijders RJ; Nicolaides KH
Ultrasound Obstet Gynecol; 1995 Jan; 5(1):15-9. PubMed ID: 7850583
[TBL] [Abstract][Full Text] [Related]
4. Fetal exomphalos and chromosomal defects: relationship to maternal age and gestation.
Snijders RJ; Sebire NJ; Souka A; Santiago C; Nicolaides KH
Ultrasound Obstet Gynecol; 1995 Oct; 6(4):250-5. PubMed ID: 8590187
[TBL] [Abstract][Full Text] [Related]
5. Prenatal diagnosis of trisomy 9.
Zuzarte R; Tan JV; Wee HY; Yeo GS
Singapore Med J; 2011 Jul; 52(7):e150-2. PubMed ID: 21808948
[TBL] [Abstract][Full Text] [Related]
6. Prenatal diagnosis of hypoplastic left heart syndrome and trisomy 18 in a fetus with normal nuchal translucency and abnormal ductus venosus blood flow at 13 weeks of gestation.
Martínez Crespo JM; Del Río M; Gómez O; Borrell A; Puerto B; Cararach V; Fortuny A
Ultrasound Obstet Gynecol; 2003 May; 21(5):490-3. PubMed ID: 12768563
[TBL] [Abstract][Full Text] [Related]
7. Discordant results between fetal cell-free DNA in maternal plasma and chorionic villus sampling in a first-trimester fetus with increased nuchal translucency and megacystis.
Sepulveda W
Ultrasound Obstet Gynecol; 2014 Sep; 44(3):369. PubMed ID: 24832209
[No Abstract] [Full Text] [Related]
8. Fetal exomphalos at 11 to 14 weeks of gestation.
Snijders RJ; Brizot ML; Faria M; Nicolaides KH
J Ultrasound Med; 1995 Aug; 14(8):569-74. PubMed ID: 7474053
[TBL] [Abstract][Full Text] [Related]
9. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
Spencer K; Souter V; Tul N; Snijders R; Nicolaides KH
Ultrasound Obstet Gynecol; 1999 Apr; 13(4):231-7. PubMed ID: 10341399
[TBL] [Abstract][Full Text] [Related]
10. Increased nuchal translucency thickness in a fetus at risk for beta-thalassaemia.
Makrydimas G; Georgiou I; Syrrou M; Skendou C; Lolis D
J Matern Fetal Med; 1997; 6(5):301-2. PubMed ID: 9360192
[TBL] [Abstract][Full Text] [Related]
11. Natural history of trisomy 21 fetuses with increased nuchal translucency thickness.
Pandya PP; Snijders RJ; Johnson S; Nicolaides KH
Ultrasound Obstet Gynecol; 1995 Jun; 5(6):381-3. PubMed ID: 7552798
[TBL] [Abstract][Full Text] [Related]
12. Pallister-Killian syndrome presenting through nuchal translucency screening for trisomy 21.
Langford K; Hodgson S; Seller M; Maxwell D
Prenat Diagn; 2000 Aug; 20(8):670-2. PubMed ID: 10951480
[TBL] [Abstract][Full Text] [Related]
13. Concomitant omphalocele and anencephaly associated with trisomy 18 and arthrogryposis diagnosed in early pregnancy.
Chen CP; Chang TY; Lin HH; Chern SR; Wang W
Taiwan J Obstet Gynecol; 2008 Mar; 47(1):93-4. PubMed ID: 18400591
[No Abstract] [Full Text] [Related]
14. Trisomy 10: first-trimester features on ultrasound, fetoscopy and postmortem of a case associated with increased nuchal translucency.
Schwärzler P; Moscoso G; Bernard JP; Hill L; Senat MV; Ville Y
Ultrasound Obstet Gynecol; 1999 Jan; 13(1):67-70. PubMed ID: 10201090
[TBL] [Abstract][Full Text] [Related]
15. Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening.
Nicolaides KH; Spencer K; Avgidou K; Faiola S; Falcon O
Ultrasound Obstet Gynecol; 2005 Mar; 25(3):221-6. PubMed ID: 15736186
[TBL] [Abstract][Full Text] [Related]
16. Early resolution of increased nuchal translucency in a fetus with trisomy 18.
Celentano C; Di Donato NG; Prefumo F; Rotmensch S
Am J Obstet Gynecol; 2003 Sep; 189(3):880-1. PubMed ID: 14526334
[TBL] [Abstract][Full Text] [Related]
17. Screening for fetal trisomy 21 in the first trimester of pregnancy: maternal serum free beta-hCG and fetal nuchal translucency thickness.
Noble PL; Abraha HD; Snijders RJ; Sherwood R; Nicolaides KH
Ultrasound Obstet Gynecol; 1995 Dec; 6(6):390-5. PubMed ID: 8903913
[TBL] [Abstract][Full Text] [Related]
18. [The prenatal detection of trisomy 13, 18, and 21: comparison of the advanced first trimester screening (AFS) with the first trimester screening according to Nicolaides].
Hörmansdörfer C; Schmidt P; Hillemanns P; Scharf A
Z Geburtshilfe Neonatol; 2007 Dec; 211(6):243-9. PubMed ID: 18176905
[TBL] [Abstract][Full Text] [Related]
19. Screening for Down's syndrome by fetal nuchal translucency measurement in a high-risk population.
Pajkrt E; Mol BW; van Lith JM; Bleker OP; Bilardo CM
Ultrasound Obstet Gynecol; 1998 Sep; 12(3):156-62. PubMed ID: 9793186
[TBL] [Abstract][Full Text] [Related]
20. Sonographic screening for trisomy 13 at 11 to 13(+6) weeks of gestation.
Papageorghiou AT; Avgidou K; Spencer K; Nix B; Nicolaides KH
Am J Obstet Gynecol; 2006 Feb; 194(2):397-401. PubMed ID: 16458636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
